Q4 2024 13F Holders as of 12/31/2024
-
Type / Class
-
Equity / Common Stock, par value $0.01 per share
-
Shares outstanding
-
34.7M
-
Number of holders
-
80
-
Total 13F shares, excl. options
-
21.7M
-
Shares change
-
-1.34M
-
Total reported value, excl. options
-
$132M
-
Value change
-
-$11.6M
-
Put/Call ratio
-
0.6
-
Number of buys
-
34
-
Number of sells
-
-23
-
Price
-
$6.11
Significant Holders of IGM Biosciences, Inc. - Common Stock, par value $0.01 per share (IGMS) as of Q4 2024
92 filings reported holding IGMS - IGM Biosciences, Inc. - Common Stock, par value $0.01 per share as of Q4 2024.
IGM Biosciences, Inc. - Common Stock, par value $0.01 per share (IGMS) has 80 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 21.7M shares
of 34.7M outstanding shares and own 62.39% of the company stock.
Largest 10 shareholders include BAKER BROS. ADVISORS LP (4.09M shares), PRICE T ROWE ASSOCIATES INC /MD/ (3.57M shares), Siren, L.L.C. (3.33M shares), Redmile Group, LLC (2.95M shares), Sanofi (1.44M shares), BlackRock, Inc. (1.05M shares), GOLDMAN SACHS GROUP INC (978K shares), VANGUARD GROUP INC (896K shares), FMR LLC (473K shares), and STATE STREET CORP (459K shares).
This table shows the top 80 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.